Bridges Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bridges Investment Counsel's BMY Position: Q4 2017 in Review
Bridges Investment Counsel increased its Bristol-Myers Squibb (BMY) stake by 0.34% in Q4 2017, buying an estimated $3.13K and bringing the position to 14,810 shares worth $908K. The position accounts for 0.5% of the portfolio, ranked #58.
Bridges Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.65M in Q1 2015. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.
- Bridges Investment Counsel held 14,810 shares of Bristol-Myers Squibb worth $908K as of Q4 2017.
- Bridges Investment Counsel bought 50 Bristol-Myers Squibb shares in Q4 2017, an estimated $3.13K.
- Bristol-Myers Squibb made up 0.5% of Bridges Investment Counsel's portfolio in Q4 2017, its #58 holding.
- Bridges Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 19 quarters since.
- Bridges Investment Counsel's Bristol-Myers Squibb position peaked at $1.65M in Q1 2015.
- 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.
Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.